Charcot-Marie-Tooth disease and Noonan syndrome with giant proximal nerve hypertrophy

Neurology

Volumn 50, Issue 4, 1998, Pages 1067-1073

  Silburn, P A ^a   Nicholson, G A ^b   Teh, B T ^c   Blair, I P ^f   Pollard, J D ^d   Nolan, P J ^e   Larsson, C ^c   Boyle, R S ^a  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b Department of Geriatric Medicine   (Australia)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^e THE PRINCE CHARLES HOSPITAL   (Australia)

^f CMM L8:01 ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CAFE AU LAIT SPOT; CHILD; CHROMOSOME 12; CLINICAL ARTICLE; DEMYELINATION; DNA DETERMINATION; FEMALE; GENE LOCUS; GENETIC LINKAGE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MALE; NEUROFIBROMATOSIS; NOONAN SYNDROME; PRIORITY JOURNAL; REMYELINIZATION;

EID: 0031923079     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.4.1067     Document Type: Article

References (32)

1. Allanson JE. Noonan syndrome. J Med Genet 1987;24:9-13.
2. Jamieson RC, van der Burgt I, Brady AF, et al. Mapping a gene for Noonan syndrome to the long arm of chromosome 12. Nat Genet 1994;8:357-360.
3. Stumpf S, Alksne JF, Annergers JF, et al. Neurofibromatosis Conference statement. Arch Neurol 1988;45:575-578.
4. Stern HJ, Saal HM, Lee JS, et al. Clinical variability of type 1 neurofibromatosis: Is there a neurofibromatosis-Noonan syndrome? J Med Genet 1992;29:184-187.
5. Opitz JM, Weaver DD. Editorial comment: the neurofibromatosis-Noonan syndrome. Am J Med Genet 1985;21: 477-490.
6. Tassabehji M, Strachan T, Sharland M, et al. Tandem duplication within a neurofibromatosis type 1 (NF1) gene exon in a family with feature of Watson syndrome and Noonan syndrome. Am J Hum Genet 1993;53:90-95.
7. Kayes LM, Burke W, Riccardi VM, et al. Deletion spanning the Neurofibromatosis gene: identification and phenotype of five patients. Am J Hum Genet 1994;54:424-436.
8. Colley A, Donnai D, Evans DGR. Neurofibromatosis/Noonan phenotype: a variable feature of type 1 neurofibromatosis. Clin Genet 1996;49:59-64.
9. Nicholson GA. Myelin gene dosage and mutation in the hereditary motor and sensory neuropathies: a review. J Neurol Neurosurg Psychiatry 1995;58:523-526.
10. Ohnishi A, Nada O. Ultrastructure of the onion bulb like structure observed in the sural nerve in a case of von Recklinghausen's disease. Acta Neuropathol (Berl) 1972;20:258-263.
11. Bradley WG, Richardson J, Frew IJC. The familial association of neurofibromatosis, peroneal muscle atrophy, congenital deafness, partial albinism and Axenfelds defect. Brain 1974; 97:521-532.
12. Bosch EP, Murphy MJ, Cancilla PA. Peripheral neurofibromatosis and peroneal muscle atrophy. Neurology 1981;31:1408-1414.
13. Thomas PK, King RHM, Chiang TR, et al. Neurofibromatosis neuropathy. Muscle Nerve 1990;13:93-101.
14. Watt JL, Stephen GS. In: Rooney DE, Czepulkowski BH, eds. Human cytogenetics - a practical approach. Washington, DC: IRL Press, 1986:46-52.
15. Lupski JR, Montes de Oca-Luna R, Slaugenhaupt S, et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 1991;66:219-232.
16. Blair IP, Nash J, Gordon MJ, Nicholson GA. Prevalence and origin of de novo duplications in Charcot-Marie-Tooth disease Type 1A: first report of a de novo duplication with a maternal origin. Am J Hum Genet 1996;58:472-476.
17. Xu G, Nelson L, O'Connell P, White R. An Alu polymorphism intragenic to the neurofibromatosis type gene (NF1). Nucleic Acids Res 1991;19:3764.
18. Lazaro C, Gaona A, Estivill X. Two CA/GT repeat polymorphisms in intron 27 of the human neurofibromatosis type 1 (NF1) gene. Hum Genet 1994;93:351-352.
19. Lazaro C, Gaona A, Xu G, et al. A highly informative CA/GT repeat polymorphism in intron 38 of the human neurofibromatosis type 1 (NF1) gene. Hum Genet 1993;92:429-430.
20. Cawthon RM, Weiss R, Xu G, et al. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure and point mutations. Cell 1990;62:193-201.
21. Wallace MR, Marchuk DA, Andersen LB, et al. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 1990;249:181-186.
22. Wilson DI, Britton SB, McKowen C, et al. Noonan's and Di-George syndromes with monosomy 22q11. Arch Dis Child 1993;68:187-189.
23. Singer ST, Hurst D, Addiego JE. Bleeding disorder in Noonan syndrome - three case reports and review of the literature. J Pediatr Hematol Oncol 1997;19:130-134.
24. Badermeunier B, Tchernia G, Mielot F, et al. Occurrence of myeloproliferative disorder in patients with Noonan syndrome. J Pediatr 1997;130:885-889.
25. Lopezmiranda B, Westra SJ, Yazdani S, Boechat MI. Noonan syndrome associated with neuroblastoma - a case report. Pediatr Radiol 1997;27:324-326.
26. Dyck PJ, Chance P, Lebo R, Carney JA. Hereditary motor and sensory neuropathies. In: Dyck PJ, Thomas PK, eds. Peripheral neuropathy, 3rd ed. Philadelphia: W.B. Saunders, 1993: 1094-1136.
27. Cusimano MD, Bilbao JM, Cohen SM. Hypertrophic brachial plexus neuritis: a pathological study of two cases. Ann Neurol 1988;24:615-622.
28. Adams RD, Ashbury AK, Michelson JI. Multifocal pseudohypertrophic neuropathy. Trans Am Neurol Assoc 1965;90:30-34.
29. Hawkes CH, Jefferson JM, Jones EL, Smith TW. Hypertrophic mononeuropathy. J Neurol Neurosurg Psychiatry 1974; 37:76-81.
30. Olsson Y. Studies on vascular permeability of peripheral nerves. 4. Distribution of intravenously injected protein tracers in the peripheral nervous system of various species. Acta Neuropathol (Berl) 1971;23:105-111.
31. Pollard JD, Selby G. Relapsing neuropathy due to tetanus toxoid. J Neurol Sci 1978;37:113-125.
32. Pollard JD, Peripheral neuropathy in diseases of thyroid and pituitary glands. In: Dyck PJ, Thomas PK, eds. Peripheral neuropathy, 3rd ed. Philadelphia: W.B. Saunders, 1993:1266-1274.